|
1) Subramanian S, Agarwal R, Deorari AK, et al. Acute renal failure in neonates. Indian J Pediatr. 2008; 75: 385-91
|
|
|
|
2) Moghal NE, Embleton ND. Management of acute renal failure in the newborn. Semin Fetal Neonatal Med. 2006; 11: 207-13
|
|
|
|
|
|
3) Luyckx VA, Brenner BM. Low birth weight, nephron number, and kidney disease. Kidney Int. 2005; 97 (suppl): S68-S77
|
|
|
|
|
|
4) Cuzzolin L, Fanos V, Pinna B, et al. Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions. Pediatr Nephrol. 2006; 21: 931-8
|
|
|
|
|
|
5) Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004; 8: R204-12
|
|
|
|
|
|
6) Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007; 11: R31
|
|
|
|
|
|
7) Akcan-Arikan A, Zappitelli M, Loftis LL, et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007; 71: 1028-35
|
|
|
|
|
|
8) Askenazi DJ, Ambalavanan N, Goldstein SL. Acute kidney injury in critically ill newborns: What do we know？ What do we need to learn？ Pediatr Nephrol. 2009; 24: 265-74
|
|
|
|
|
|
9) Palevsky PM. Indications and timing of renal replacement therapy in acute kidney injury. Crit Care Med. 2008; 36 (suppl): S224-8
|
|
|
|
|
|
10) Goldstein SL, Currier H, Graf JM, et al. Outcome in children receiving continuous venovenous hemofiltration. Pediatrics. 2001; 107: 1309-12
|
|
|
|
|
|
11) Gillespie RS, Seidel K, Symons JM. Effect of fluid overload and dose of replacement fluid on survival in hemofiltration. Pediatr Nephrol. 2004; 19: 1394-9
|
|
|
|
|
|
12) Foland JA, Fortenberry JD, Warshaw BL, et al. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med. 2004; 32: 1771- 6
|
|
|
|
|
|
13) Goldstein SL, Somers MJG, Baum MA, et al. Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int. 2005; 67: 653-8
|
|
|
|
|
|
14) Nguyen MT, Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol. 2008; 23: 2151-67
|
|
|
|
|
|
15) Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005; 365: 1231-8
|
|
|
|
|
|
16) Parikh CR, Mishra J, Thiessen-Philbrook H, et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2006; 70: 199-203
|
|
|
|
|
|
17) Zappitelli M, Washburn KK, Arikan AA, et al. Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care. 2007; 11: R84
|
|
|
|
|
|
18) Washburn KK, Zappitelli M, Arikan AA, et al. Urinary interleukin-18 is an acute kidney injury biomarker in critically ill children. Nephrol Dial Transplant. 2008; 23: 566-72
|
|
|
|
|
|
19) Lavery AP, Meinzen-Derr JK, Anderson E, et al. Urinary NGAL in premature infants. Pediatr Res. 2008; 64: 423-8
|
|
|
|
|
|
20) Hackbarth R, Bunchman TE, Chua AN, et al. The effect of vascular access location and size on circuit survival in pediatric continuous renal replacement therapy: a report from the PPCRRT registry. Int J Artif Organs. 2007; 30: 1116-21
|
|
|
|
|
|
21) Coulthard MG, Sharp J. Haemodialysing infants: theoretical limitations, and single versus double lumen lines. Pediatr Nephrol. 2001; 16: 332-4
|
|
|
|
|
|
22) Symons JM. Renal replacement therapy for the critically ill infant. In: Ronco C, Bellomo R, Kellum JA, editors. Critical Care Nephrology. 2nd ed. Philadelphia: Saunders Elsevier; 2009. p. 1625-9
|
|
|
|
|
|
23) Goldstein SL. Overview of pediatric renal replacement therapy in acute kidney injury. Semin Dial. 2009; 22: 180-4
|
|
|
|
|
|
24) 石川 健, 高田 彰, 相馬洋紀, 他. 血液浄化装置の安全監視機能が使用可能な低容量回路の作製. 日小児腎臓病会誌. 2006; 19: 65-9
|
|
|
|
|
25) Pasko DA, Mottes TA, Mueller BA. Pre dialysis of blood prime in continuous hemodialysis normalizes pH and electrolytes. Pediatr Nephrol. 2003; 18: 1177-83
|
|
|
|
|
|
26) Hackbarth RM, Eding D, Gianoli C, et al. Zero balance ultrafiltration (Z-BUF) in blood-primed CRRT circuits achieves electrolyte and acid-base homeostasis prior to patient connection. Pediatr Nephrol. 2005; 20: 1328-33
|
|
|
|
|
|
27) Brophy PD, Mottes TA, Kudelka TL, et al. AN-69 membrane reactions are pH-dependent and preventable. Am J Kidney Dis. 2001; 38: 173-8
|
|
|
|
|
|
28) 平山千佳. 血液透析. In: 伊藤克己. 小児急性血液浄化療法マニュアル. 東京: 医学図書出版; 2002. p. 55-64
|
|
|
|
|
|
29) Everdell NL, Coulthard MG, Crosier J, et al. A machine for haemodialysing very small infants. Pediatr Nephrol. 2005; 20: 636-43
|
|
|
|
|
|
30) Strazdins V, Watson AR, Harvey B. Renal replacement therapy for acute renal failure in children: European Guidelines. Pediatr Nephrol. 2004; 19: 199-207
|
|
|
|
|
|
31) del Castillo J, López-Herce J, Cidoncha E, et al. Circuit life span in critically ill children on continuous renal replacement treatment: a prospective observational evaluation study. Crit Care. 2008; 12: R93
|
|
|
|
|
|
32) Chadha V, Garg U, Warady BA, et al. Citrate clearance in children receiving continuous venovenous renal replacement therapy. Pediatr Nephrol. 2002; 17: 819-24
|
|
|
|
|
|
33) MacLaren G, Butt W. Controversies in paediatric continuous renal replacement therapy. Intensive Care Med. 2009; 35: 596-602
|
|
|
|
|
|
34) Bunchman TE, Maxvold NJ, Barnett J, et al. Pediatric hemofiltration: Normocarb dialysate solution with citrate anticoagulation. Pediatric Nephrol. 2002; 17: 150-4
|
|
|
|
|
|
35) Brophy PD, Somers MJG, Baum MA, et al. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant. 2005; 20: 1416-21
|
|
|
|
|
|
36) Monchi M, Berghmans D, Ledoux D, et al. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med. 2004; 30: 260-5
|
|
|
|
|
|
37) Symons JM, Chua AN, Somers MJG, et al. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the Prospective Pediatric Continuous Renal Replacement Therapy Registry. Clin J Am Soc Nephrol. 2007; 2: 732-8
|
|
|
|
|
|
38) Symons JM, Brophy PD, Gregory MJ, et al. Continuous renal replacement therapy in children up to 10 kg. Am J Kidney Dis. 2003; 41: 984-9
|
|
|
|
|
|
39) Parakininkas D, Greenbaum LA. Comparison of solute clearance in three modes of continuous renal replacement therapy. Pediatr Crit Care Med. 2004; 5: 269-74
|
|
|
|
|
|
40) 高田 彰, 石川 健. 急性腎不全動物モデルを用いた低血流量時の血液浄化効率に関する研究. 岩手医誌. 2005; 57: 147-53
|
|
|
|
|
|
41) 相馬洋紀, 高田 彰, 石川 健. 急性腎不全動物モデルを用いた低血流量時の血液濾過, 血液透析濾過の効率に関する研究. 岩手医誌. 2006; 58: 155-62
|
|
|
|
|
|
42) Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomized trial. Lancet. 2000; 355: 26-30
|
|
|
|
|
|
43) Bauman CSC, Oudemans-van Straaten HM, Tijssen JGP, et al. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med. 2002; 30: 2205-11
|
|
|
|
|
|
44) Tolwani AJ, Campbell RC, Stofan BS, et al. Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol. 2008; 19: 1233-8
|
|
|
|
|
|
45) The VA/NIH Acute Renal Failure Trial Network. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008; 359: 7-20
|
|
|
|
|
|
46) The RENAL Replacement Therapy Study Investigators. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009; 361: 1627-38
|
|
|
|
|